Italia markets open in 6 hours 24 minutes

Ypsomed Holding AG (0QLQ.L)

LSE - LSE Prezzo differito. Valuta in CHF.
Aggiungi a portafoglio
172,12-2,44 (-1,40%)
Alla chiusura: 05:29PM GMT

Ypsomed Holding AG

Brunnmattstrasse 6
Burgdorf 3401
Switzerland
41 34 424 41 11
http://www.ypsomed.com

Settore/i
Settore
Impiegati a tempo pieno1.900

Figure dirigenziali chiave

NomeTitoloRetribuzioneEsercitateAnno di nascita
Mr. Simon MichelChief Exec. Officer850,5kN/D1977
Mr. Niklaus RamseierChief Financial OfficerN/DN/D1963
Mr. Frank MengisCOO & Sr. VP of OperationsN/DN/D1964
Mr. Hans-Ulrich LehmannSr. VP of Technology & CTON/DN/D1966
Thomas KuttHead of Investor RelationsN/DN/DN/D
Dr. Beat MaurerSr. VP of Legal Services & Intellectual Property and Sec. of the BoardN/DN/D1958
Mr. Michael ZauggSr. VP of HRN/DN/D1972
Ms. Ulrike BauerSr. VP of Delivery SystemsN/DN/D1969
Dr. Eberhard BauerSr. VP of Diabetes CareN/DN/D1960
Gli importi risalgono al giorno 31 dicembre 2021 e i valori di compensazione riguardano l'anno fiscale che si chiude a tale data. La retribuzione include salari, bonus ecc. "Esercitate" è il valore delle opzioni esercitate durante l'anno fiscale. Valuta in CHF.

Descrizione

Ypsomed Holding AG, together with its subsidiaries, develops, manufactures, and sells injection and infusion systems for pharmaceutical and biotechnology companies. The company operates in two segments, Ypsomed Delivery Systems and Ypsomed Diabetes Care. The Ypsomed Delivery Systems segment provides various injection systems, such as pen injectors, auto injectors, patch injectors, and wearable injectors, as well as other smart devices. This segment offers its products under the YDS brand. The Ypsomed Diabetes Care segment sells and trades in insulin pumps, infusion sets, pen needles, blood glucose monitoring systems, accessories, and other day-to-day items for diabetics. This segment offers its products under the mylife brand name. The company offers precision turned parts; and contract manufacturing and other services. It markets its products through biotechnology and pharmaceutical partners, as well as through its own distribution network and independent distributors. The company operates in Switzerland, Europe, North America, and internationally. Ypsomed Holding AG was founded in 1984 and is headquartered in Burgdorf, Switzerland.

Governance aziendale

L'ISS Governance QualityScore di Ypsomed Holding AG al 26 settembre 2021 è 9. I criteri di valutazione fondamentali sono revisione: 7; Consiglio di Amministrazione: 10; diritti degli azionisti: 1; retribuzione: 6.

Punteggi di corporate governance forniti da Institutional Shareholder Services (ISS). I punteggi indicano il rango decile relativo all’indice o alla regione. Un punteggio di decile pari a 1 indica un governance risk più basso, mentre un punteggio di 10 indica un governance risk più alto.